IMMIX BIOPHARMA, INC. — Balance Sheet Charts
2 snapshots of history · ending 2022-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Working Capital Components
Total Assets
$15M
Current Assets
$15M
Cash & Equivalents
$13M
ST Investments
—
Net PPE
$4K
Total Liabilities
$2M
Current Liabilities
$1M
Account Payables
$143K
Stockholders Equity
$13M
Retained Earnings
$-38M
Operating Lease ROU Asset
—
Operating Lease Liability
—
Gross PP&E
—
Accumulated Depreciation
—